Evaluating Use Patterns of and Adherence to Medications for Benign Prostatic Hyperplasia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating Use Patterns of and Adherence to Medications for Benign Prostatic Hyperplasia

Published:2009-05 Issue:5 Volume:181 Page:2214-2222
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Nichol Michael B.¹,Knight Tara K.¹,Wu Joanne¹,Barron Richard²,Penson David F.³

Affiliation:

1. Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, University of Southern California, Los Angeles, California

2. Allergan Corp., Irvine, California

3. Department of Urology, University of Southern California, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference25 articles.

1. Changing therapeutic regimens in benign prostatic hyperplasia;Stoevelaar;Pharmacoeconomics,2001

2. The progression of benign prostatic hyperplasia: examining the evidence and determining the risk;Anderson;Eur Urol,2001

3. Optimising the medical management of benign prostatic hyperplasia;Marberger;Eur Urol,2004

4. Impact of treatment on sexuality;Schulman;Prostate Cancer Prostatic Dis,2001

5. Medical management of BPH: the debate continues;Debruyne;Eur Urol,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and network meta‐analysis of re‐intervention rates of new surgical interventions for benign prostatic hyperplasia;BJU International;2024-04-10

2. Standard approach and future perspective for the management of benign prostatic hyperplasia from a health-economics point of view: the role of transperineal laser ablation;Frontiers in Urology;2023-02-24

3. Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy);Healthcare;2022-12-17

4. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study;Prostate Cancer and Prostatic Diseases;2022-06-10

5. Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients;Asian Journal of Urology;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3